The evaluation of free influenza vaccination in health care workers in a medical center in Taiwan

Pharmacy World and Science

Volumn 30, Issue 1, 2008, Pages 39-43

  Chan, Agnes L F ^a,b,c   Shie, Huei Jen ^a   Lee, Yung Jin ^c   Lin, Shun Jin ^c  

^a CHI MEI MEDICAL CENTER   (Taiwan)

^b CHIA NAN UNIVERSITY OF PHARMACY AND SCIENCE   (Taiwan)

^c KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Adverse drug reactions; Cost; Healthcare worker; Influenza; Influenze vaccine; Taiwan

Indexed keywords

INFLUENZA VACCINE;

ABSENTEEISM; ADULT; ARTICLE; CLINICAL EVALUATION; CONTROLLED STUDY; COST CONTROL; COST EFFECTIVENESS ANALYSIS; ERYTHEMA; FATIGUE; FEMALE; FEVER; FLU LIKE SYNDROME; HEADACHE; HEALTH CARE PERSONNEL; HOSPITAL; HOSPITAL COST; HUMAN; INCIDENCE; INFLUENZA VACCINATION; INJECTION SITE PAIN; MALE; MYALGIA; OUTCOME ASSESSMENT; PRURITUS; QUESTIONNAIRE; STATISTICAL ANALYSIS; TAIWAN;

ABSENTEEISM; ADULT; COST-BENEFIT ANALYSIS; FEMALE; HUMANS; IMMUNIZATION PROGRAMS; INCIDENCE; INFLUENZA VACCINES; INFLUENZA, HUMAN; MALE; OCCUPATIONAL HEALTH SERVICES; OUTCOME ASSESSMENT (HEALTH CARE); PERSONNEL, HOSPITAL; PILOT PROJECTS; QUESTIONNAIRES; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; SICK LEAVE; TAIWAN;

EID: 36448977917     PISSN: 09281231     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11096-007-9137-8     Document Type: Article

References (15)

1. Center for Disease Control Taiwan. www.cdc.gov.tw.
2. Cram P, Blitz SG, Monto A, et al. Influenza- Cost of illness and considerations in the economic evaluation of new and emerging therapies. Pharmacoeconomics 2001;19(3):223-30.
3. Akazawa M, Sindelar JL, Paltiel D. Economic costs of influenza related work. Absenteeism. Value in Health 2003;6(2):107-15.
4. Wang CS, Wang ST, Chou P. Efficacy and cost-effectiveness of influenza vaccination of the elderly in a densely populated and unvaccinated community. Vaccine 2002;20:2494-9.
5. Wang ST, Lee LT, Chen LS, Chen HH. Economic evaluation of vaccination against influenza in the elderly: an experience from a population-based influenza vaccination program in Taiwan. Vaccine 2005;23:1973-80.
6. Nichol KL, Lind A, Margolis KL, Murdogh M, et al. The effectiveness of vaccination against influenza in healthy, working adults. N Engl J Med 1995;33:889-93.
7. Bridges CB, Thompson WW, Meltzer MI, Reeve GR, et al. Effectiveness and cost-benefit of influenza vaccination of healthy working adults, a randomized controlled trial. JAMA 2000;284(13):1655-63.
8. Nichol KL. Cost-benefit analysis of a strategy to vaccinate healthy working adults against influenza. Arch Intern Med 2001;161:749-59.
9. Morales A, Martinez MM, Tisseau AT, Rey E, et al. Costs and benefits of influenza vaccination and work productivity in a Colombian company from the employer's perspective. Value in Health 2004;7(4):433-41.
10. Gupa RD, Guest JF. A model to estimate the cost benefit of an occupational vaccination program for influenza with Influvac in the UK. Pharmacoeconomic 2002;20(7):475-84.
11. Demicheli V, Jefferson T, Rivetti D, Deek J. Prevention and early treatment of influenza in healthy adults. Vaccine 2000;18(11-12):957-1030.
12. Demicheli V, Rivetti D, Deeks JJ, Jefferson TO. Vaccines for preventing influenza in healthy adults. Cochrane Database Syst Rev 2004;(3):CD001269.
13. Center for Disease Control and Prevention. Interventions to increase influenza vaccination of healthcare workers-California and Minnesota. MMWR Morb Mortal Wkly Rep 2005;4:54.
14. Weinstein MC, Stason WB. Foundations of cost-effectiveness analysis for health and medical practices. N Engl J Med 1977;296:716-21.
15. Douglas CS, Maria RH. Cost-effectiveness of the influenza vaccine in a healthy, working age population. J Occup Environ Med 1997;39(5):408-14.